KBC Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$353K Buy
1,462
+165
+13% +$39.8K ﹤0.01% 738
2025
Q1
$316K Sell
1,297
-984
-43% -$240K ﹤0.01% 836
2024
Q4
$749K Sell
2,281
-814
-26% -$267K ﹤0.01% 778
2024
Q3
$1.04M Buy
3,095
+1,400
+83% +$469K ﹤0.01% 682
2024
Q2
$463K Sell
1,695
-557
-25% -$152K ﹤0.01% 730
2024
Q1
$779K Sell
2,252
-1,044
-32% -$361K ﹤0.01% 692
2023
Q4
$1.06M Sell
3,296
-1,534
-32% -$495K ﹤0.01% 681
2023
Q3
$1.73M Sell
4,830
-548
-10% -$196K 0.01% 607
2023
Q2
$2.04M Buy
5,378
+1,781
+50% +$675K 0.01% 600
2023
Q1
$1.72M Sell
3,597
-284
-7% -$136K 0.01% 666
2022
Q4
$1.63M Buy
3,881
+2,263
+140% +$952K 0.01% 636
2022
Q3
$675K Buy
1,618
+28
+2% +$11.7K ﹤0.01% 716
2022
Q2
$787K Buy
1,590
+80
+5% +$39.6K ﹤0.01% 690
2022
Q1
$850K Sell
1,510
-29,581
-95% -$16.7M ﹤0.01% 722
2021
Q4
$23.5M Sell
31,091
-1,844
-6% -$1.39M 0.08% 242
2021
Q3
$24.6M Buy
32,935
+25,351
+334% +$18.9M 0.09% 228
2021
Q2
$4.89M Buy
7,584
+1,346
+22% +$867K 0.01% 625
2021
Q1
$3.56M Buy
6,238
+1,558
+33% +$890K 0.01% 665
2020
Q4
$15M Hold
4,680
0.01% 712
2020
Q3
$2.41M Sell
4,680
-68,744
-94% -$35.4M 0.01% 679
2020
Q2
$33.2M Buy
73,424
+54,132
+281% +$24.4M 0.11% 185
2020
Q1
$6.76M Buy
19,292
+17,723
+1,130% +$6.21M 0.06% 309
2019
Q4
$581K Buy
+1,569
New +$581K ﹤0.01% 1064
2015
Q4
Sell
-2,232
Closed -$300K 1266
2015
Q3
$300K Buy
+2,232
New +$300K 0.01% 903